General
Preferred name
MELOXICAM
Synonyms
Mobic ()
Metacam ()
Movalis ()
Meloxicam (Mobic) ()
Meloxicam71125-38-7 ()
Inflacam ()
Emdocam ()
Acticam ()
Meloxivet ()
Movatec ()
Coxicam ()
Flexicam ()
UH-AC-62 XX ()
Vivlodex ()
N1539 ()
Melovem ()
N-1539 ()
Melosus ()
UHAC-62XX ()
Revitacam ()
Recocam ()
Rheumocam ()
Melfax ()
Meloxidolor ()
Meloxoral ()
Contacera ()
Loxicom ()
Meloxidyl ()
Anjeso ()
Qmiiz odt ()
UH-AC 62XX ()
Meloxicam-d3 ()
P&D ID
PD001257
CAS
71125-38-7
942047-63-4
Tags
natural product
drug
available
Approved by
FDA
First approval
2000
Drug Status
approved
vet_approved
Drug indication
Arthritis
Anti-Inflammatory (nonsteroidal)
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic actions. (GtoPdb)
Compound Sets
24
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
63
Properties
(calculated by RDKit )
Molecular Weight
351.03
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
1.95
TPSA
99.6
Fraction CSP3
0.14
Chiral centers
0.0
Largest ring
6.0
QED
0.86
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Immunology/Inflammation
Neuroscience
Apoptosis
Autophagy
Metabolic Enzyme/Protease
Target
COX
PTGS1, PTGS2
MMP
Indication
osteoarthritis, rheumatoid arthritis
MOA
cyclooxygenase inhibitor
Source data